BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32762514)

  • 1. Designing novel epitope-based polyvalent vaccines against herpes simplex virus-1 and 2 exploiting the immunoinformatics approach.
    Sarkar B; Ullah MA; Araf Y; Das S; Rahman MH; Moin AT
    J Biomol Struct Dyn; 2021 Oct; 39(17):6585-6605. PubMed ID: 32762514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contriving a chimeric polyvalent vaccine to prevent infections caused by herpes simplex virus (type-1 and type-2): an exploratory immunoinformatic approach.
    Hasan M; Islam S; Chakraborty S; Mustafa AH; Azim KF; Joy ZF; Hossain MN; Foysal SH; Hasan MN
    J Biomol Struct Dyn; 2020 Jul; 38(10):2898-2915. PubMed ID: 31328668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatics Approach to Design Novel Subunit Vaccine against the Epstein-Barr Virus.
    Moin AT; Patil RB; Tabassum T; Araf Y; Ullah MA; Snigdha HJ; Alam T; Alvey SA; Rudra B; Mina SA; Akter Y; Zhai J; Zheng C
    Microbiol Spectr; 2022 Oct; 10(5):e0115122. PubMed ID: 36094198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoinformatics analysis to design novel epitope based vaccine candidate targeting the glycoprotein and nucleoprotein of Lassa mammarenavirus (LASMV) using strains from Nigeria.
    Abass OA; Timofeev VI; Sarkar B; Onobun DO; Ogunsola SO; Aiyenuro AE; Aborode AT; Aigboje AE; Omobolanle BN; Imolele AG; Abiodun AA
    J Biomol Struct Dyn; 2022 Oct; 40(16):7283-7302. PubMed ID: 33719908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus.
    Ullah MA; Sarkar B; Islam SS
    Immunobiology; 2020 May; 225(3):151949. PubMed ID: 32444135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritization of potential vaccine candidates and designing a multiepitope-based subunit vaccine against multidrug-resistant Salmonella Typhi str. CT18: A subtractive proteomics and immunoinformatics approach.
    Chand Y; Singh S
    Microb Pathog; 2021 Oct; 159():105150. PubMed ID: 34425197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive screening of the whole proteome of hantavirus and designing a multi-epitope subunit vaccine for cross-protection against hantavirus: Structural vaccinology and immunoinformatics study.
    Abdulla F; Nain Z; Hossain MM; Syed SB; Ahmed Khan MS; Adhikari UK
    Microb Pathog; 2021 Jan; 150():104705. PubMed ID: 33352214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining of Ebola virus genome for the construction of multi-epitope vaccine to combat its infection.
    Shankar U; Jain N; Mishra SK; Sk MF; Kar P; Kumar A
    J Biomol Struct Dyn; 2022 Jul; 40(11):4815-4831. PubMed ID: 33463407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinformatics-guided designing and in silico analysis of epitope-based polyvalent vaccines against multiple strains of human coronavirus (HCoV).
    Sarkar B; Ullah MA; Araf Y; Islam NN; Zohora US
    Expert Rev Vaccines; 2022 Dec; 21(12):1851-1871. PubMed ID: 33435759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome-wide screening for designing a multi-epitope vaccine against emerging pathogen
    Nain Z; Abdulla F; Rahman MM; Karim MM; Khan MSA; Sayed SB; Mahmud S; Rahman SMR; Sheam MM; Haque Z; Adhikari UK
    J Biomol Struct Dyn; 2020 Oct; 38(16):4850-4867. PubMed ID: 31709929
    [No Abstract]   [Full Text] [Related]  

  • 11. Blueprint of epitope-based multivalent and multipathogenic vaccines: targeted against the dengue and zika viruses.
    Sarkar B; Ullah MA; Araf Y; Das S; Hosen MJ
    J Biomol Struct Dyn; 2021 Nov; 39(18):6882-6902. PubMed ID: 32772811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach.
    Sarkar B; Ullah MA; Araf Y; Rahman MS
    Inform Med Unlocked; 2020; 21():100478. PubMed ID: 33200088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational designing of a novel subunit vaccine for human cytomegalovirus by employing the immunoinformatics framework.
    Moin AT; Singh G; Ahmed N; Saiara SA; Timofeev VI; Ahsan Faruqui N; Sharika Ahsan S; Tabassum A; Nebir SS; Andalib KMS; Araf Y; Ullah MA; Sarkar B; Islam NN; Zohora US
    J Biomol Struct Dyn; 2023 Feb; 41(3):833-855. PubMed ID: 36617426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
    Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
    Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of broadly reactive epitopes targeting major glycoproteins of Herpes simplex virus (HSV) 1 and 2 - An immunoinformatics analysis.
    Chauhan V; Goyal K; Singh MP
    Infect Genet Evol; 2018 Jul; 61():24-35. PubMed ID: 29524615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome-wide mapping and reverse vaccinology-based B and T cell multi-epitope subunit vaccine designing for immune response reinforcement against
    Khan S; Ali SS; Zaheer I; Saleem S; Ziaullah ; Zaman N; Iqbal A; Suleman M; Wadood A; Rehman AU; Khan A; Khan A; Wei DQ
    J Biomol Struct Dyn; 2022 Feb; 40(2):833-847. PubMed ID: 32928063
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrating pan-genome and reverse vaccinology to design multi-epitope vaccine against Herpes simplex virus type-1.
    Roy A; Swetha RG; Basu S; Biswas R; Ramaiah S; Anbarasu A
    3 Biotech; 2024 Jul; 14(7):176. PubMed ID: 38855144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of next-generation polyvalent vaccine candidates against three important poxviruses by targeting DNA-dependent RNA polymerase using an integrated immunoinformatics and molecular modeling approach.
    Kumar A; Dutt M; Dehury B; Martinez GS; Singh KP; Kelvin DJ
    J Infect Public Health; 2024 Jul; 17(7):102470. PubMed ID: 38865776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
    Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
    J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.